Karin Harumi Uchima Koecklin
Tatsuo Shimosawa
Peng Li- 1Life Sciences Institute, University of Michigan, Ann Arbor, MI, United States
- 2Department of Biologic and Materials Sciences, School of Dentistry, University of Michigan, Ann Arbor, MI, United States
- 3Department of Molecular and Integrative Physiology, School of Medicine, University of Michigan, Ann Arbor, MI, United States
- 4Department of Clinical Laboratory, Faculty of Medicine, International University of Health and Welfare, Chiba, Japan
Editorial on the Research Topic
Endocrine consequences of sleep disorders
Sleep is a vital physiological process necessary for sustaining both physical health and optimal brain function (1–3). Despite the recommended sleep duration of 7 to 9 hours for adults, achieving this has become increasingly challenging in today’s society due to the rising rates of sleep disorders and sleep deprivation (4, 5). Disruption in sleep has been associated with various endocrine disorders, such as obesity, type 2 diabetes mellitus, and thyroid hormone dysregulation. This Research Topic strives to enhance our comprehension of the intricate relationship between sleep and endocrine disorders, with the ultimate goal of advancing the treatment approaches for these pathological conditions.
One of the most prevalent sleep disturbances is sleep apnea, specifically obstructive sleep apnea (OSA), which affects nearly 1 billion adults worldwide between the ages of 30 and 69 (6, 7). OSA is closely associated with obesity, as 40% of people with a BMI over 30 also have OSA (7). Obesity is considered a significant risk factor for the development and progression of OSA, while OSA also contributes to weight gain and difficulty in losing weight. In this Research Topic, the study of Ma et al. focused on the association between OSA and abdominal fat distribution in adult Chinese patients with obesity. This cross-sectional study found that the prevalence of OSA in obese patients was high, with increased neck circumference in patients with severe OSA, and increased visceral fat area in all patients with OSA. Moreover, the abdominal visceral adipose tissue accumulation was also increased in obese patients with OSA and posed as a risk for the development of OSA. These findings have implications for the diagnosis and treatment of OSA in obese patients, highlighting the importance of considering these factors in clinical approaches.
A common treatment option to promote weight loss in obese patients is bariatric surgery. Approximately 45% of obese patients with OSA undergo this procedure, which not only aids in weight reduction but also improves their sleep quality and OSA condition (8). In line with this, Leentjens et al. investigated on the level of angiopoietin-like protein 7 (ANGPTL7), a member of the ANGPTL family that play a role in inducing insulin resistance, in patients with different severity of OSA who underwent bariatric surgery by conducting a prospective cohort study in Netherlands. ANGPTL7 exhibited a positive correlation with the apnea-hypopnea index in moderate and severe OSA cases. Interestingly, bariatric surgery significantly decreased the levels of ANGPTL7 in all patients, regardless of the severity of OSA, accompanied by a decrease in the apnea-hypopnea index. These findings highlight the potential involvement of ANGPTL7 in OSA and suggest its potential utility as a diagnostic and prognostic marker in OSA patients undergoing bariatric surgery.
Type 2 diabetes mellitus (T2DM) is another pathological condition that is associated with OSA (9). Understanding the association between OSA and T2DM is crucial because both conditions are complex and can have overlapping pathophysiological mechanisms. The study of Worku et al. further addressed the risk of OSA in T2DM patients and its predictors with a cross-sectional study in Ethiopia. Their results showed a nearly 32% prevalence of OSA in T2DM patients. Other risk factors for OSA they reported include male sex, physical inactivity, higher neck circumference, and comorbid hypertension. Similarly, Guo et al. studied the relationship between T2DM and the respiratory event duration in patients referred to a sleep clinic for the diagnosis of OSA. Their results showed that a decreased respiratory duration increased the odds of T2DM while a shorter apnea duration would be not only associated with this disease, but also with poor sleep quality and lower arousal threshold. Therefore, these studies provide valuable insights into the significance of evaluating and assessing OSA in T2DM patients.
To further complicate the relationship between T2DM and sleep disturbance, it is important to consider that not only does the disease itself is associated with sleep issues, but the medical treatment of T2DM can also impact sleep quality (10). T2DM patients usually present sleep difficulties, which could be a side effect of the medicine used to manage hyperglycemia in these patients. Taking this into consideration, Xue et al. evaluated the association between oral antidiabetic therapy and sleep in T2DM patients from the UK Biobank. Through the analysis of a large cohort, the study revealed that patients using non-metformin medications had a higher likelihood of experiencing difficulties in both falling asleep and staying asleep compared to both metformin users and untreated patients. Additionally, non-metformin users presented longer sleep duration than untreated and metformin patients. These findings underscore the significance of considering the choice of antidiabetic medication and its potential association with sleep disturbances. Taken together, these studies suggest that identifying and addressing sleep issues in T2DM patients can help optimize the treatment outcomes and enhance overall quality of life.
Another endocrine problem that is associated with sleep disturbances is thyroid dysfunction. Green et al. discussed in their review about the effects of thyroid dysfunctions on sleep, highlighting the implication of thyroid hormone dysregulation in various sleep disturbances. In light of this, it is important to note that untreated conditions such as hyperthyroidism and hypothyroidism can significantly impair both the quantity and quality of sleep, consequently exerting a profound influence on the overall health of other body systems.
Circadian rhythm has been suggested to be associated with metabolic health and food intake (11, 12). The perspective article of Marino and Arble provided valuable insights into the mechanisms linking peripheral clock disruption and metabolic diseases by reviewing multiple studies. The authors highlight the significance of cyclic clock genes in peripheral tissues and their association with metabolic disorders, which provides insights into the underlying mechanisms that contribute to metabolic disease in relation to circadian disruption and diverse sleep disorders.
In this Research Topic, we present seven studies that explore various facets of the intricate relationship between sleep and endocrine disorders. These findings offer valuable insights that can contribute to a more informed clinical approach toward these interconnected phenomena, particularly as their incidence continues to rise each year.
Author contributions
All authors have contributed to the preparation of the editorial and have reviewed and approved the final submitted version.
Funding
PL is supported by National Institutes of Health grants (R01 AT011652 and R01 HL156989).
Acknowledgments
We would like to thank all the authors and reviewers for their invaluable contributions that have greatly contributed to the success of this Research Topic.
Conflict of interest
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Publisher’s note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.
References
1. Gallicchio L, Kalesan B. Sleep duration and mortality: a systematic review and meta-analysis. J Sleep Res (2009) 18:148–58. doi: 10.1111/j.1365-2869.2008.00732.x
2. Krause AJ, Simon E Ben, Mander BA, Greer SM, Saletin JM, Goldstein-Piekarski AN, et al. The sleep-deprived human brain. Nat Rev Neurosci (2017) 18:404–18. doi: 10.1038/nrn.2017.55
3. Morrison M, Halson SL, Weakley J, Hawley JA. Sleep, circadian biology and skeletal muscle interactions: implications for metabolic health. Sleep Med Rev (2022) 66:101700. doi: 10.1016/j.smrv.2022.101700
4. Hirshkowitz M, Whiton K, Albert SM, Alessi C, Bruni O, DonCarlos L, et al. National sleep foundation’s updated sleep duration recommendations: final report. Sleep Health (2015) 1:233–43. doi: 10.1016/j.sleh.2015.10.004
5. Acquavella J, Mehra R, Bron M, Suomi JM, Hess GP. Prevalence of narcolepsy and other sleep disorders and frequency of diagnostic tests from 2013-2016 in insured patients actively seeking care. J Clin Sleep Med (2020) 16:1255–63. doi: 10.5664/jcsm.8482
6. Benjafield AV, Ayas NT, Eastwood PR, Heinzer R, Ip MSM, Morrell MJ, et al. Estimation of the global prevalence and burden of obstructive sleep apnoea: a literature-based analysis. Lancet Respir Med (2019) 7:687–98. doi: 10.1016/S2213-2600(19)30198-5
7. Veasey SC, Rosen IM. Obstructive sleep apnea in adults. N Engl J Med (2019) 380:1442–9. doi: 10.1056/NEJMcp1816152
8. Haines KL, Nelson LG, Gonzalez R, Torrella T, Martin T, Kandil A, et al. Objective evidence that bariatric surgery improves obesity-related obstructive sleep apnea. Surgery (2007) 141:354–8. doi: 10.1016/j.surg.2006.08.012
9. Lévy P, Kohler M, McNicholas WT, Barbé F, McEvoy RD, Somers VK, et al. Obstructive sleep apnoea syndrome. Nat Rev Dis Primers (2015) 1:15015. doi: 10.1038/nrdp.2015.15
10. Kajbaf F, Fendri S, Basille-Fantinato A, Diouf M, Rose D, Jounieaux V, et al. The relationship between metformin therapy and sleep quantity and quality in patients with type 2 diabetes referred for potential sleep disorders. Diabetes Med (2014) 31:577–80. doi: 10.1111/dme.12362
11. Challet E. The circadian regulation of food intake. Nat Rev Endocrinol (2019) 15:393–405. doi: 10.1038/s41574-019-0210-x
Keywords: sleep disorders, endocrine disorders, obstructive sleep apnea, obesity, thyroid dysfunction, sleep apnea, circadian disruption, diabetes
Citation: Uchima Koecklin KH, Shimosawa T and Li P (2023) Editorial: Endocrine consequences of sleep disorders. Front. Endocrinol. 14:1238950. doi: 10.3389/fendo.2023.1238950
Received: 12 June 2023; Accepted: 14 June 2023;
Published: 29 June 2023.
Edited and Reviewed by:
James M. Olcese, Florida State University, United StatesCopyright © 2023 Uchima Koecklin, Shimosawa and Li. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
*Correspondence: Peng Li, cGVuZ2xpdW1AdW1pY2guZWR1